vs
Side-by-side financial comparison of Jaguar Health, Inc. (JAGX) and TOP Financial Group Ltd (TOP). Click either name above to swap in a different company.
Jaguar Health, Inc. is the larger business by last-quarter revenue ($3.2M vs $2.9M, roughly 1.1× TOP Financial Group Ltd). TOP Financial Group Ltd runs the higher net margin — 6.6% vs -717.2%, a 723.9% gap on every dollar of revenue.
Jaguar Health, Inc.JAGXEarnings & Financial Report
Jaguar Health, Inc. is a commercial-stage biopharmaceutical firm developing and selling plant-derived prescription medicines for humans and animals. Its products target unmet gastrointestinal treatment needs, with main markets in North America and select European regions, covering human health and animal health segments.
Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.
JAGX vs TOP — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.2M | $2.9M |
| Net Profit | $-23.2M | $190.5K |
| Gross Margin | 32.0% | — |
| Operating Margin | -656.6% | — |
| Net Margin | -717.2% | 6.6% |
| Revenue YoY | -7.8% | — |
| Net Profit YoY | -133.9% | — |
| EPS (diluted) | $10.27 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.2M | — | ||
| Q3 25 | $3.1M | $2.9M | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $2.2M | — | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $2.4M | — |
| Q4 25 | $-23.2M | — | ||
| Q3 25 | $-9.5M | $190.5K | ||
| Q2 25 | $-10.4M | — | ||
| Q1 25 | $-10.5M | — | ||
| Q4 24 | $-9.9M | — | ||
| Q3 24 | $-9.9M | — | ||
| Q2 24 | $-9.5M | — | ||
| Q1 24 | $-9.2M | — |
| Q4 25 | 32.0% | — | ||
| Q3 25 | 82.7% | — | ||
| Q2 25 | 82.3% | — | ||
| Q1 25 | 76.7% | — | ||
| Q4 24 | 84.1% | — | ||
| Q3 24 | 82.6% | — | ||
| Q2 24 | 84.3% | — | ||
| Q1 24 | 81.7% | — |
| Q4 25 | -656.6% | — | ||
| Q3 25 | -234.8% | — | ||
| Q2 25 | -268.8% | — | ||
| Q1 25 | -425.5% | — | ||
| Q4 24 | -232.5% | — | ||
| Q3 24 | -233.7% | — | ||
| Q2 24 | -264.5% | — | ||
| Q1 24 | -349.4% | — |
| Q4 25 | -717.2% | — | ||
| Q3 25 | -308.2% | 6.6% | ||
| Q2 25 | -349.3% | — | ||
| Q1 25 | -472.6% | — | ||
| Q4 24 | -282.7% | — | ||
| Q3 24 | -317.1% | — | ||
| Q2 24 | -348.8% | — | ||
| Q1 24 | -392.4% | — |
| Q4 25 | $10.27 | — | ||
| Q3 25 | $-6.28 | — | ||
| Q2 25 | $-10.26 | — | ||
| Q1 25 | $-16.70 | — | ||
| Q4 24 | $-14.62 | — | ||
| Q3 24 | $-1.05 | — | ||
| Q2 24 | $-4.04 | — | ||
| Q1 24 | $-0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $968.0K | $14.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-18.7M | $35.0M |
| Total Assets | $38.3M | $64.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $968.0K | — | ||
| Q3 25 | $3.5M | $14.8M | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $5.7M | — | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $13.3M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $4.4M | $35.0M | ||
| Q2 25 | $6.9M | — | ||
| Q1 25 | $830.0K | — | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $16.6M | — | ||
| Q1 24 | $11.8M | — |
| Q4 25 | $38.3M | — | ||
| Q3 25 | $49.5M | $64.1M | ||
| Q2 25 | $48.3M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $53.4M | — | ||
| Q3 24 | $58.5M | — | ||
| Q2 24 | $61.5M | — | ||
| Q1 24 | $55.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-7.3M | — | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.0M | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JAGX
| Human Health Segment | $3.2M | 97% |
| Other | $83.0K | 3% |
TOP
Segment breakdown not available.
